Kit For The Preparation Of Technetium Tc shortage — US supply status & alternatives

Kit For The Preparation Of Technetium Tc

—

🇦🇺 AUST R 315900

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Yes — under S19A

TGA s19A · mebrofenin-kit-preparation-technetium-tc-99m-mebrofenin-injection-usa

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Therapeutic category
Active ingredient (INN)	Kit For The Preparation Of Technetium Tc

Controlled substance	No

Marketing-authorisation holders	Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific, Lantheus Medical Imaging, Inc., SUN PHARMACEUTICAL INDUSTRIES, INC., Jubilant DraxImage Inc., dba Jubilant Radiopharma +3 more

Registrations on file	15

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

✓

Section 19A approval in force · mebrofenin-kit-preparation-technetium-tc-99m-mebrofenin-injection-usa

TGA Section 19A: overseas-registered 'Mebrofenin kit for the preparation of Technetium Tc 99m mebrofenin for injection (USA)' approved for import and supply in Australia during a shortage. Origin: USA. Expires Jan 2027. Verify on TGA Section 19A approvals ↗

Shortage status by regulator official notices

🇺🇸

United States

FDA-FE · 2h ago

High

Recalls official enforcement reports

🇺🇸

Kit For The Preparation Of Technetium Tc

Jubilant Draximage Inc., dba Jubilant Radiopharma · Nov 2024

Class IIdetails ↗

Verified timeline regulator events

🇺🇸 22 Nov 2024

high reported

Sources official regulators

🇺🇸

FDA-FE

verified 2h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders15 registrations · 7 MA holders

Product	Strength	Form	Market	MA holder	Status
Jubilant MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated	—	—	🇦🇺 AU	—	Active
DRAXIMAGE MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated	—	—	🇦🇺 AU	Global Medical Solutions Australia Pty Limited T/A Radpharm Scientific	Active
Drax MAA kit for the preparation of Technetium Tc 99m Albumin Aggregated	—	—	🇦🇺 AU	—	Active
DRAXIMAGE MACROSALB kit for the preparation of Technetium Tc 99m Albumin Aggregated	—	—	🇦🇺 AU	—	Active
Kit for the Preparation of Technetium Tc99m Sestamibi	1mg/mL	injection	🇺🇸 US	Lantheus Medical Imaging, Inc.	Active
Kit for the Preparation of Technetium Tc 99M Medronate	20mg/10mL	injection	🇺🇸 US	SUN PHARMACEUTICAL INDUSTRIES, INC.	Active
Kit for the Preparation of Technetium Tc99m Pyrophosphate	12mg/10mL	injection	🇺🇸 US	SUN PHARMACEUTICAL INDUSTRIES, INC.	Active
Kit for the Preparation of Technetium Tc 99m Mebrofenin	45mg/10mL	injection	🇺🇸 US	SUN PHARMACEUTICAL INDUSTRIES, INC.	Active
Kit for the Preparation of Technetium Tc99m Sestamibi	1mg/10mL	injection	🇺🇸 US	SUN PHARMACEUTICAL INDUSTRIES, INC.	Active
Kit for the Preparation of Technetium Tc99m Mertiatide	1mg/1	injection	🇺🇸 US	SUN PHARMACEUTICAL INDUSTRIES, INC.	Active
Kit for the Preparation of Technetium Tc 99m Sulfur Colloid	—	kit	🇺🇸 US	Jubilant DraxImage Inc., dba Jubilant Radiopharma	Active
Kit for the Preparation of Technetium Tc99m Sestamibi	1mg/5mL	injection	🇺🇸 US	Cardinal Health 414, LLC	Active
Kit for the Preparation of Technetium Tc 99m Medronate	20mg/1	injection	🇺🇸 US	Cardinal Health 414, LLC	Active
Kit for the Preparation of Technetium Tc 99m Pentetate	20mg/mL	injection	🇺🇸 US	CURIUM US LLC	Active
Kit For The Preparation Of Technetium Tc 99m Sestamibi	—	solution	🇨🇦 CA	CURIUM CANADA INC	Active

Mederti Drug Report

Generated 1 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.